The Union Minister for Chemicals and Fertilizers DV Sadananda Gowda announced that the Centre has allocated a total of 23680 additional vials of Amphotericin- B to all states and Union Territories. This has been decided on Saturday after reviewing the rising number of cases of Mucormycosis or black fungus infections in various states.
Taking to Twitter, Gowda informed that the allocation has been made based on the total number of patients, which is approximately counted on 8848 across the country.
“After a detailed review of rising number of cases of Mucormycosis in various states, a total of 23680 additional vials of Amphotericin- B have been allocated to all States/UTs today. The Allocation has been made based on the total number of patients which is approximately 8848 across the country,” the Union Minister tweeted.
The Allocation has been made based on total no. of patients which is approx. 8848 across country. pic.twitter.com/JPsdEHuz0W
— Sadananda Gowda (@DVSadanandGowda) May 22, 2021
According to a list of Mucormycosis cases reported across the country cited by the Minister, Gujarat has a maximum number of cases (2281), followed by Maharastra (2000) and Andhra Pradesh (910).
The Ministry had earlier said, “Moreover, anyone who is diabetic and whose immune system is not functioning well needs to be on the guard against this. The disease is caused by a set of micro-organisms known as mucormycetes, which are present naturally in the environment, seen mostly in soil and in decaying organic matter like leaves, compost and piles.”
Among the patients who are recovering or have recovered from COVID-19 is being detected with Mucormycosis, as per the Union Health Ministry.
It has been studied that the treatment of patients with coronavirus involves the intake of drugs like dexamethasone, which suppresses our immune system response.
Due to these factors, COVID-19 patients face a renewed risk of failing the battle against the attacks mounted by the group of organisms called mucormycetes.